In COVID-19, it is assumed that the expression of membrane-bound ACE2 is reduced by mechanisms such as internalization of SARS-CoV2 upon intracellular entry and cleavage to its soluble form by activation of TNF-α converting enzyme due to inflammation (63). Here, ACE2 is linked to COVID-19.